Colchicine and Spironolactone in Patients with MI / SYNERGY Stent Registry
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 7264 participants.
Also called NCT03048825
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 7,264 participants
- Sponsor
- Registry
-
NCT03048825
-
- Other papers using this trial's data
- Colchicine in Acute Myocardial Infarction
- Routine Spironolactone in Acute Myocardial Infarction
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States, Australia, Canada, Czechia, Egypt, France, Hungary, Nepal, Netherlands, North Macedonia, Serbia, Spain, Switzerland, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT03048825. Randomized; quadruple masking; primary purpose treatment. Start 2018-02-01 (actual); primary completion 2024-08-09 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Colchicine and Spironolactone in Patients with MI / SYNERGY Stent Registry
- Acronym
- CLEAR SYNERGY
- Condition
- ST Elevation Myocardial Infarction
- Condition
- Non ST Elevation Myocardial Infarction
- Intervention (Drug)
- Colchicine
- Intervention (Drug)
- Spironolactone
- Intervention (Device)
- SYNERGY Bioabsorbable Polymer Drug-Eluting Stent
- Intervention (Drug)
- Colchicine-Placebo
- Intervention (Drug)
- Spironolactone-Placebo
- Lead sponsor
- Population Health Research Institute
- Collaborator
- Boston Scientific Corporation
- Collaborator
- Canadian Institutes of Health Research (CIHR)
Record details
- Record id
cardio:ct-nct03048825- Content hash
188f38b0b74460b5377207837421b2b1537202f128164d2bb25d082c4781dee7